Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole MR-based Concomitant Quadruple Therapy for H. pylori
NCT03829150Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexlansoprazole in Helicobacter pylori infection (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: The rates of H.pylori eradication at 8 weeks. Started Mar 2017; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03829150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03829150.